Patents by Inventor Conor Lynch

Conor Lynch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR INHIBITION OF MULTIPLE MYELOMA
    Publication number: 20210323949
    Abstract: Novel compounds (small molecules) that potently and selectively inhibit MMP-13 (i.e., MMP-13 inhibitors) are used for treatment of multiple myeloma. The MMP-13 inhibitors described herein are highly selective for MMP-13 and when administered to an individual in need thereof, the compounds selectively kill multiple myeloma cells, reduce growth of multiple myeloma cells, inhibit multiple myeloma-induced osteoclastogenesis, and increase survival time in the individual.
    Type: Application
    Filed: June 28, 2019
    Publication date: October 21, 2021
    Applicants: FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES, H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Gregg B. Fields, Conor Lynch
  • Enhanced call barring
    Publication number: 20050009503
    Abstract: A system 230, communications unit 101, and method (FIG. 3), for dynamically controlling access to services in an unobtrusive manner is disclosed, where the method includes receiving a request for services (303) and denying the request until a security screen is satisfied (315), unless those services have been recently accessed (309).
    Type: Application
    Filed: July 10, 2003
    Publication date: January 13, 2005
    Inventors: Tom Bourke, Conor Lynch, Colm O'Farrell